H.RES.449: Relating to breast implants, the Food and Drug Administration, and breast care.

About This Bill

  • This bill was introduced in the 104th Congress
  • This bill is primarily about education
  • Introduced June 6, 1996
  • Latest Major Action June 14, 1996

Bill Summary

Expresses the sense of the House of Representatives that: (1) the Food and Drug Administration should issue a definitive statement on the relationship (or lack thereof) between silicone gel breast implants and connective tissue disease, classic auto-immune symptoms, and other serious diseases; and (2) the Food and Drug Administration and the National Cancer Institute should develop recommendations for breast care for women with breast implants.

(Source: Library of Congress)

Bill Actions

Date Description
Referred to the House Committee on Commerce.
Sponsor introductory remarks on measure.
Referred to the Subcommittee on Health and Environment.
June 6, 1996

Introduced in the House by Barbara Farrell Vucanovich (R-Nev.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page